Welcome to LookChem.com Sign In|Join Free

CAS

  • or

873943-00-1

Post Buying Request

873943-00-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

873943-00-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 873943-00-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,3,9,4 and 3 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 873943-00:
(8*8)+(7*7)+(6*3)+(5*9)+(4*4)+(3*3)+(2*0)+(1*0)=201
201 % 10 = 1
So 873943-00-1 is a valid CAS Registry Number.

873943-00-1Downstream Products

873943-00-1Relevant articles and documents

Identification and evaluation of 4-anilinoquin(az)olines as potent inhibitors of both dengue virus (DENV) and Venezuelan equine encephalitis virus (VEEV)

Asquith, Christopher R. M.,Einav, Shirit,Huang, Pei-Tzu,Saul, Sirle

, (2021/11/01)

There is an urgent need for novel strategies for the treatment of emerging arthropod-borne viral infections, including those caused by dengue virus (DENV) and Venezuelan equine encephalitis virus (VEEV). We prepared and screened focused libraries of 4-anilinoquinolines and 4-anilinoquinazolines for antiviral activity and identified three potent compounds. N-(2,5-dimethoxyphenyl)-6-(trifluoromethyl)quinolin-4-amine (10) inhibited DENV infection with an EC50 = 0.25 μM, N-(3,4-dichlorophenyl)-6-(trifluoromethyl)quinolin-4-amine (27) inhibited VEEV with an EC50 = 0.50 μM, while N-(3-ethynyl-4-fluorophenyl)-6,7-dimethoxyquinazolin-4-amine (54) inhibited VEEV with an EC50 = 0.60 μM. These series of compounds demonstrated nearly no toxicity with CC50 values greater than 10 μM in all cases. These promising results provide a future prospective to develop a clinical compound against these emerging viral threats.

METHODS AND COMPOSITIONS FOR THE TREATMENT OF BODY COMPOSITION DISORDERS

-

Page/Page column 43, (2008/12/07)

This invention relates to methods of treating, managing and preventing body composition disorders, and to compounds and pharmaceutical compositions useful in such methods.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 873943-00-1